720 related articles for article (PubMed ID: 21720257)
21. [Indoleamine 2,3-dioxygenase activity in breast cancer patients with local recurrence or distant metastases].
Sakurai K; Fujisaki S; Suzuki S; Nagashima S; Maeda T; Tomita R; Hara Y; Hirano T; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1304-6. PubMed ID: 25335725
[TBL] [Abstract][Full Text] [Related]
22. Low indoleamine 2,3-dioxygenase activity in persistent food allergy in children.
Buyuktiryaki B; Sahiner UM; Girgin G; Birben E; Soyer OU; Cavkaytar O; Cetin C; Arik Yilmaz E; Yavuz ST; Kalayci O; Baydar T; Sackesen C
Allergy; 2016 Feb; 71(2):258-66. PubMed ID: 26449488
[TBL] [Abstract][Full Text] [Related]
23. Tryptophan-kynurenine profile in pediatric autoimmune hepatitis.
Lytton SD; Osiecki M; MałgorzataWoźniak ; Cukrowska B; Wierzbicka A; Goliszek M; Socha P; Janczyk W; Dayanakli D; Abendroth D; Kramp S; Fechner K; Scheper T; Mahler M; Bentow C; Bogdanos D; Fuchs D; Woynarowski M
Immunol Res; 2019 Feb; 67(1):39-47. PubMed ID: 30666511
[TBL] [Abstract][Full Text] [Related]
24. Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality.
Pertovaara M; Raitala A; Lehtimäki T; Karhunen PJ; Oja SS; Jylhä M; Hervonen A; Hurme M
Mech Ageing Dev; 2006 May; 127(5):497-9. PubMed ID: 16513157
[TBL] [Abstract][Full Text] [Related]
25. Immunobiochemical pathways of neopterin formation and tryptophan breakdown via indoleamine 2,3-dioxygenase correlate with circulating tumor cells in ovarian cancer patients- A study of the OVCAD consortium.
Gostner JM; Obermayr E; Braicu IE; Concin N; Mahner S; Vanderstichele A; Sehouli J; Vergote I; Fuchs D; Zeillinger R
Gynecol Oncol; 2018 May; 149(2):371-380. PubMed ID: 29530331
[TBL] [Abstract][Full Text] [Related]
26. Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma.
Engin A; Gonul II; Engin AB; Karamercan A; Sepici Dincel A; Dursun A
World J Gastroenterol; 2016 Apr; 22(13):3592-601. PubMed ID: 27053851
[TBL] [Abstract][Full Text] [Related]
27. Serum indoleamine 2,3 dioxygenase and tryptophan and kynurenine ratio using the UPLC-MS/MS method, in patients undergoing peritoneal dialysis, hemodialysis, and kidney transplantation.
Yilmaz N; Ustundag Y; Kivrak S; Kahvecioglu S; Celik H; Kivrak I; Huysal K
Ren Fail; 2016 Sep; 38(8):1300-9. PubMed ID: 27466137
[TBL] [Abstract][Full Text] [Related]
28. Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement.
Zinellu A; Sotgia S; Mangoni AA; Sanna M; Satta AE; Carru C
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):153-9. PubMed ID: 25534866
[TBL] [Abstract][Full Text] [Related]
29. Early Posttransplant Tryptophan Metabolism Predicts Long-term Outcome of Human Kidney Transplantation.
Vavrincova-Yaghi D; Seelen MA; Kema IP; Deelman LE; van der Heuvel MC; Breukelman H; Van den Eynde BJ; Henning RH; van Goor H; Sandovici M
Transplantation; 2015 Aug; 99(8):e97-104. PubMed ID: 25651307
[TBL] [Abstract][Full Text] [Related]
30. Serum indoleamine 2,3-dioxygenase activity predicts prognosis of pulmonary tuberculosis.
Suzuki Y; Suda T; Asada K; Miwa S; Suzuki M; Fujie M; Furuhashi K; Nakamura Y; Inui N; Shirai T; Hayakawa H; Nakamura H; Chida K
Clin Vaccine Immunol; 2012 Mar; 19(3):436-42. PubMed ID: 22219312
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori and serum kynurenine-tryptophan ratio in patients with colorectal cancer.
Engin AB; Karahalil B; Karakaya AE; Engin A
World J Gastroenterol; 2015 Mar; 21(12):3636-43. PubMed ID: 25834331
[TBL] [Abstract][Full Text] [Related]
32. Determination of kynurnine and tryptophan, biomarkers of indoleamine 2,3-dioxygenase by LC-MS/MS in plasma and tumor.
Wang W; Zhuang X; Liu W; Dong L; Sun H; Du G; Ye L
Bioanalysis; 2018 Aug; 10(16):1335-1344. PubMed ID: 30130131
[TBL] [Abstract][Full Text] [Related]
33. Canine mast cell tumour cells regulate tryptophan catabolism via the expression of indoleamine 2,3-dioxygenase.
Matsuda A; Hata A; Tanaka A; Matsuda H
Res Vet Sci; 2021 Jul; 137():159-162. PubMed ID: 33984619
[TBL] [Abstract][Full Text] [Related]
34. [Indoleamine 2,3-dioxygenase activity during chemotherapy in patients with breast cancer].
Sakurai K; Matsuo S; Enomoto K; Tani M; Kitajima A; Amano S
Gan To Kagaku Ryoho; 2009 Nov; 36(12):1991-3. PubMed ID: 20037301
[TBL] [Abstract][Full Text] [Related]
35. Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma.
Corm S; Berthon C; Imbenotte M; Biggio V; Lhermitte M; Dupont C; Briche I; Quesnel B
Leuk Res; 2009 Mar; 33(3):490-4. PubMed ID: 18639339
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients.
Zhou QH; Han H; Lu JB; Liu TY; Huang KB; Deng CZ; Li ZS; Chen JP; Yao K; Qin ZK; Liu ZW; Li YH; Guo SJ; Ye YL; Zhou FJ; Liu RY
Cancer Commun (Lond); 2020 Jan; 40(1):3-15. PubMed ID: 32125093
[TBL] [Abstract][Full Text] [Related]
37. Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival.
Ferns DM; Kema IP; Buist MR; Nijman HW; Kenter GG; Jordanova ES
Oncoimmunology; 2015 Feb; 4(2):e981457. PubMed ID: 25949879
[TBL] [Abstract][Full Text] [Related]
38. [Indoleamine 2, 3-dioxygenase activity during neoadjuvant chemotherapy in patients with breast cancer].
Sakurai K; Fujisaki S; Nagashima S; Maeda T; Tomita R; Suzuki S; Hara Y; Hirano T; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1578-80. PubMed ID: 24393854
[TBL] [Abstract][Full Text] [Related]
39. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma.
Masaki A; Ishida T; Maeda Y; Suzuki S; Ito A; Takino H; Ogura H; Totani H; Yoshida T; Kinoshita S; Narita T; Ri M; Kusumoto S; Inagaki A; Komatsu H; Niimi A; Ueda R; Utsunomiya A; Inagaki H; Iida S
Clin Cancer Res; 2015 Jun; 21(12):2830-9. PubMed ID: 25788494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
